PMID: 11920588Mar 29, 2002Paper

Transcriptional inactivation of TP73 expression in oligodendroglial tumors

International Journal of Cancer. Journal International Du Cancer
Shumin DongHo-keung Ng

Abstract

The TP73 gene, located on chromosome 1p36.3, encodes a product that shares significant structural homology with the tumor suppressor TP53. The aim of this study was to investigate whether TP73 is involved in the development of oligodendroglial tumors, which frequently carry deletions involving 1p36.3. Semi-quantitative reverse transcription-polymerase chain reaction was used to determine TP73 transcript levels. Ten of 24 (42%) tumors showed negligible to more than 5-fold reduction in TP73 expression when compared to normal brain level. To identify potential mechanisms that may modulate TP73 transcription in oligodendroglial tumors, we performed mutation analysis on the TP73 gene. No somatic mutations were however detected in the gene sequence. We then evaluated the possible involvement of epigenetic change in TP73 expression. Bisulfite genomic sequencing detected aberrant hypermethylation at the 5' region upstream and including the first exon of the TP73 gene in 17 of 44 (39%) oligodendroglial tumors, whereas normal brain tissues showed no methylation in the same region examined. Moreover, 6 of 10 (60%) tumors with negligible or decreased levels of TP73 transcripts were methylation-positive. In conclusion, our results showed th...Continue Reading

References

Jun 22, 1995·International Journal of Cancer. Journal International Du Cancer·M J BelloJ A Rey
Sep 1, 1995·Journal of Neuropathology and Experimental Neurology·W H YongD N Louis
Jan 1, 1995·Journal of Neuropathology and Experimental Neurology·J A KrausA von Deimling
Aug 11, 1994·Nucleic Acids Research·S J ClarkM Frommer
Oct 17, 1998·Molecular and Cellular Biology·M C MarinW G Kaelin
Oct 17, 1998·Journal of the National Cancer Institute·J G CairncrossD N Louis
Oct 31, 1998·International Journal of Cancer. Journal International Du Cancer·Y NimuraA Nakagawara
Nov 6, 1998·The Journal of Experimental Medicine·V De LaurenziG Melino
Feb 24, 1999·Journal of Neuropathology and Experimental Neurology·Y ChengK W Lo
Apr 13, 1999·Archives of Neurology·J R PerryJ G Cairncross
May 7, 1999·Histopathology·C Y TongJ C Lee
Jun 11, 1999·Oncogene·H YoshikawaC C Harris
Jun 22, 1999·Journal of Neuropathology and Experimental Neurology·J W JeukenR H Boerman
Nov 26, 1999·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·Y DingT Sakai
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Jun 23, 2001·Oncogene·M R RountreeS B Baylin
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·S M DongH K Ng

❮ Previous
Next ❯

Citations

Jul 10, 2003·Cancer Genetics and Cytogenetics·M Eva AlonsoJuan A Rey
Jan 22, 2004·Cancer Genetics and Cytogenetics·Jesus LomasJuan A Rey
Aug 4, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Josena K StephenMaria J Worsham
Nov 26, 2003·Neuropathology and Applied Neurobiology·E RousseauM Vikkula
Dec 3, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Josena K StephenMaria J Worsham
Feb 5, 2013·Neurosurgical Focus·Nicholas F Marko, Robert J Weil
Apr 1, 2009·International Journal of Molecular Sciences·Markus J Riemenschneider, Guido Reifenberger
Apr 7, 2015·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Brittany Baur, Serdar Bozdag
Aug 24, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Christian HartmannAndreas von Deimling
Feb 15, 2011·Clinical Epigenetics·Josena K StephenMaria J Worsham
Sep 24, 2010·Seminars in Diagnostic Pathology·Fausto J Rodriguez, Caterina Giannini
Mar 31, 2009·International Journal of Cancer. Journal International Du Cancer·Lu-Ting KuoYong-Kwang Tu
Jul 5, 2003·Cancer Science·Norihiro MasudaHiroyuki Kuwano
Sep 16, 2006·Neuropathology and Applied Neurobiology·J FelsbergA Waha
Aug 6, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Sun-Wei GuoAndré Kajdacsy-Balla
Apr 20, 2014·British Journal of Neurosurgery·Radim Jancalek
Jun 3, 2016·Journal of Neuropathology and Experimental Neurology·Peter J DickinsonDanika Bannasch
Oct 22, 2008·Expert Review of Neurotherapeutics·Luke B HessonFarida Latif
Sep 2, 2003·International Journal of Cancer. Journal International Du Cancer·Audrey PlayerJin Jen
Apr 13, 2005·International Journal of Cancer. Journal International Du Cancer·Hongzhi ZouDavid A Ahlquist
Apr 30, 2003·The Journal of Biological Chemistry·Veronica VellaJean Y J Wang
Jan 28, 2005·Journal of Neuro-oncology·Judith W M JeukenPieter Wesseling
Feb 13, 2003·Journal of Neuropathology and Experimental Neurology·Guido Reifenberger, David N Louis
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie Si LiuHextan Yuen-Sheung Ngan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.